|
|
|
|
| LEADER |
03190cam a2200289Ia 4500 |
| 001 |
43467 |
| 008 |
950529s1995 enka b 101 0 eng d |
| 020 |
|
|
|a 1858730511
|
| 040 |
|
|
|a TRMEMSKU
|
| 049 |
|
|
|a TR7VH
|
| 050 |
0 |
0 |
|a RC669
|b NEW 1995
|
| 245 |
1 |
0 |
|a New horizons in diabetes mellitus and cardiovascular disease /
|c edited by Colin J. Schwartz, Gustav V.R. Born ; with foreword by Sir Philip Randle.
|
| 246 |
3 |
0 |
|a Diabetes mellitus and cardiovascular disease
|
| 260 |
|
|
|a London :
|b Current Science,
|c c1995.
|
| 300 |
|
|
|a 224 s. :
|b res. ;
|c 28 cm.
|
| 504 |
|
|
|a Bibliyografya ve dizin var.
|
| 505 |
0 |
|
|a Type II diabetes and its macrovascular complications -- Insulin resistance and hyperinsulinemia: the link betwwen NIDDM, CAD, hypertension and dyslipidemia -- The role of angiotensin-I converting enzyme gene in the pathogenesis of non-insulin-dependent diabetes mellitus -- Glucose recognition and other signalling events in insulin secretion -- The insulin receptor, insulin action and the mechanisms of insulin resistance in diabetes and atherosclerosis -- The immune system and diabetes mellitus -- The impact of diabetes mellitus on public health in Mexico -- The Metabolic Disease Syndrome: lessons to be learned from racial and ethnic diversity -- The coagulation system, diabetes and cardiovascular diseases -- Plasma lipids in diabetes -- Low-density lipoprotein size in patients with NIDDM and the insulin resistance syndrome -- Lipid and lipoprotein advanced glycosylation in diabetic cardiovascular disease -- Oxidative stress and diabetes mellitus -- Cellular and molecular mechanisms in the macroangiopathy of diabetes -- Role of abnormal platelet function in the vascular complicatios of diabetes mellitus -- The nature and consequences of microvascular disease in diabetes mellitus -- Proinsulin and cardiovascular risk -- Is insulin-like growth factor-1 a cardiovascular risk factor? The effects of diabetic autonomic neuropathy on the cardiovascular system -- The pathogenesis of diabetic neuropathy -- UK Prospective Diabetes Study: 3-year update -- Management of hyptertension in the diabetic patient: evolving concepts -- Pathogenesis and management of diabetic nephropathy -- Pancreatic transplantation, implantable insulin pumps, and hybrid artificial pancreas -- Alpha-glucosidase inhibition, a new therapeutic principle in the management of diabetes mellitus -- Treatment of non-insulin-dependent (type II) diabetes with alpha-glucosidase inhibitors.
|
| 650 |
|
0 |
|a Cardiovascular system
|x Diseases
|v Congresses.
|9 187637
|
| 650 |
|
0 |
|a Diabetes
|x Complications
|v Congresses.
|9 187638
|
| 650 |
|
4 |
|a Kardiyovasküler Sistem
|x Hastalıklar
|v Kongreler.
|9 187639
|
| 650 |
|
4 |
|a Şeker Hastalığı
|x Sorunlar
|v Kongreler.
|9 187640
|
| 700 |
1 |
|
|a Schwartz, Colin John,
|d 1931-
|9 25624
|
| 700 |
1 |
|
|a Born, Gustav V. R.
|9 25630
|
| 111 |
2 |
|
|a William Harvey Research Institute/University of Texas Health Sciences Center at San Antonio Conference
|n (2nd :
|d 1994 :
|c Cancun, Mexico)
|9 187641
|
| 942 |
|
|
|2 lcc
|
| 999 |
|
|
|c 37735
|d 37735
|
| 952 |
|
|
|0 0
|1 0
|2 lcc
|4 0
|5 0
|6 RC0669 N E W1995
|7 0
|9 57081
|a MK
|b MK
|c MK
|d 2005-10-27
|e S
|l 4
|o RC669 NEW 1995
|p 0072558
|r 2019-12-18
|s 2019-12-17
|t 1
|w 2005-10-27
|y KT
|